LFB Biomanufacturing
Bertrand Digonnet is an accomplished professional in the field of quality management, currently serving as Directeur Qualite at LFB Biomanufacturing since July 2017. Prior to this role, Bertrand held various positions at GlaxoSmithKline Biologicals from August 2002 to July 2017, including Primary GMP QA Senior Manager, where notable contributions included leading a project to improve the Deviation Handling Process. Bertrand's earlier experience includes serving as Site Quality Manager at Bristol-Meyers Squibb from July 1996 to July 2002. Educational qualifications include a Docteur en pharmacie and a degree as Pharmacyst from Faculte de Pharmacie Paris XI, completed between 1986 and 1993.
This person is not in the org chart
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.